Last reviewed · How we verify
Racecadotril suspension
At a glance
| Generic name | Racecadotril suspension |
|---|---|
| Also known as | Tiorfast® |
| Sponsor | Bioprojet |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea (PHASE3)
- Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in Children (NA)
- Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Racecadotril suspension CI brief — competitive landscape report
- Racecadotril suspension updates RSS · CI watch RSS
- Bioprojet portfolio CI